• 1-800-880-6491

Health Services

Healthcare services companies partner with MCI to elevate their profile in the capital markets and reach a wider audience in the investment community

Contact UsSubscribe
Investor Sentiment Snapshot

Health Services

Investor Sentiment Analysis

Health Services

2025 has provided healthcare services investors with a welcome return to value accretion following multiple years where the sector as a whole profoundly underperformed the broader market / S&P 500. While investor sentiment remains muted towards certain names in the health services sector, 2025 has marked an interesting inflection point for the sector, driven by innovation, resilience, and strategic growth. That said, valuations amongst peers remain highly variable. Investors remain skeptical about whether roll-up plays are actually achieving the synergies, economies of scale, and returns initially promised.

Investors in the health services sector are increasingly favoring innovation that improves access to care, patient outcomes, and system efficiency. Institutional investors are prioritizing scalability, payer-provider integration, and proof of value in clinical and economic terms. Amid regulatory complexity and rising costs, investors want clear value conversion paths and a compelling ESG narrative. For Canadian firms, alignment with national health system goals and cost-effectiveness is essential to investor appeal.

The Health Services Sector's

Challenges

Health services companies face a complex set of structural and macro challenges:

  • Fragmented data systems, lack of interoperability, and difficulties in achieving synergies on their acquisitions
  • Regulatory hurdles, including privacy, reimbursement, and digital health approvals
  • Difficult capital-raising environment given the sector’s underperformance
  • Workforce shortages driving inefficiencies across service models
  • Investor skepticism toward unprofitable rollup strategies or overly niche solutions
The Health Services Sector's

Opportunities

Despite challenges, the industry offers significant growth potential for companies positioned around transformation and efficiency:

  • AI-driven automation of diagnostics, care coordination, and clinical decision support
  • Government incentives and policies supporting digital transformation in healthcare
  • Strong appetite for integrated solutions across the care continuum
Implications for your

Investor Relations & Capital Markets Strategy

Effective health services investor relations in 2025 demands a nuanced understanding of both capital markets and healthcare delivery transformation. IR teams must align messaging with investor priorities around patient outcomes, scalable business models, and payer/provider adoption. Given increasing investor scrutiny related to revenue predictability and the path to value creation, companies must articulate how their solutions integrate within existing systems, reduce the cost of care, enhance profitability, and drive measurable value.

Capital markets strategy should emphasize commercial traction, customer retention metrics, and strategic partnerships with payers, providers, and health systems. For Canadian companies, highlighting alignment with provincial and federal health modernization goals can strengthen cross-border investor interest. Firms must be prepared to discuss the regulatory environment proactively and in detail  particularly with respect to privacy and AI in diagnostics.

Investors also expect transparency around data use, security protocols, and ESG practices, particularly as healthcare becomes more digital. M&A positioning should be framed around ecosystem integration, defensibility, and strategic moats rather than scale alone. IR should use investor days, whitepapers, and earnings materials to reinforce leadership’s domain expertise, customer insights, and long-term vision. In this evolving market, clear, credible, and consistent communication will differentiate the winners.

Our Capabilities
MCI Capabilities

Activist Resolution

MCI Capabilities

Corporate Communications

MCI Capabilities

Capital Markets
Strategy

MCI Capabilities

Crisis
Communications

MCI Capabilities

Debt and Equity
Offerings

MCI Capabilities

Financial
Reporting

MCI Capabilities

Design &
Branding

MCI Capabilities

Digital
Technologies

MCI Capabilities

ESG &
Sustainability

MCI Capabilities

Investor Perception
Studies

MCI Capabilities

Initial Public
Offerings

MCI Capabilities

Ongoing Investor
Relations

MCI Capabilities

Investment
Grade Events

MCI Capabilities

Market
Coaching

MCI Capabilities

Market
Connect

MCI Capabilities

Market
Turnaround

MCI Capabilities

Transaction
Communications

Learn more about the capital markets

Access Our Insights

MCI Capital Markets and AxialBridge to Deliver Integrated De-risking and Capital Access Platform for Life Science Companies

MCI and AxialBridge to Deliver Integrated De-risking and Capital Access Platform for Life Science Companies

 MCI and AxialBridge to Deliver Integrated De-risking and Capital Access Platform for Life Science Companies 1024 576 Tom McMillan

The MCI – AxialBridge partnership will make complex science investable by providing a single, coordinated pathway from bench to bedside to balance sheet.

MCI Capital Markets Presents for the TMX Alpha Catalyst Series - Part of the TSX IR Accelerator 2026

TSX IR Accelerator 2026

 TSX IR Accelerator 2026 1024 576 Tom McMillan

MCI Capital Markets is proud to be a presenting partner for TMX Group‘s launch of Alpha Catalyst: TSX IR Accelerator 2026 for Toronto Stock Exchange and TSX Venture Exchange companies.

Strategies for when Activists Investors are Stalking You

How do you address an activist investor stalking your company?

 How do you address an activist investor stalking your company? 1024 576 Tom McMillan

Are you being stalked by an activist investor quietly accumulating your stock? This guide shows how to respond. From identifying activists early, using stock surveillance to monitor their activity, and engaging with activists constructively, learn how preparation, open communication, and proactive strategy tweaks can turn an activist threat into an opportunity for positive change.

Post Davos 2026 Investor Strategies

In the Aftermath of Davos 2026, How Should Companies Adapt Their Investor Strategy?

 In the Aftermath of Davos 2026, How Should Companies Adapt Their Investor Strategy? 1024 576 Todd Coakwell

Companies must adapt their capital markets and investor strategies post Davos 2026. Davos clarified the risks investors must now actively price, from geopolitical exposure and trade volatility to capital allocation discipline. This article explains what changed at Davos and how global companies should adapt their disclosure and capital markets strategy to maintain credibility, manage investor expectations, and protect valuation.

The Death of Sustainability and ESG

Is Sustainability Dead or Has the Market Simply Moved On?

 Is Sustainability Dead or Has the Market Simply Moved On? 1024 576 Todd Coakwell

Is sustainability dead? Not exactly. While ESG narratives and public commitments have pulled back, capital markets still rely on sustainability data through risk, governance, and financial lenses. This article explains why sustainability has reset, how regulators slowed momentum, and what investors, banks, analysts, and IR teams still need today.

How Should Public Companies Prepare to Raise Capital in the Public Markets?

How To Prepare to Raise Capital in the Public Markets

 How To Prepare to Raise Capital in the Public Markets 1024 576 Tom McMillan

Raising capital in the public markets can unlock new growth for an established company. However, success requires diligent preparation and strategy. This post outlines how public companies can prepare effectively – from defining the use of proceeds and planning the raise, choosing between equity vs debt, tailoring investor communications, building key relationships, and executing a capital raise with confidence.

Stock Splits and Consolidations (Reverse stock splits)

Stock Splits and Consolidations – The Risks and Benefits to Capital Market Performance

 Stock Splits and Consolidations – The Risks and Benefits to Capital Market Performance 1024 576 Tom McMillan

Stock splits and reverse stock splits do not create value on their own. However, they play an important role in how public companies manage liquidity, accessibility, and investor perception. This article explains when stock splits and share consolidation make sense, the risks involved, and how boards and management teams should frame these decisions within a broader capital markets strategy.

Returning Capital to Shareholders

Returning Capital to Shareholders: Dividends, Special Payouts, and Share Buybacks

 Returning Capital to Shareholders: Dividends, Special Payouts, and Share Buybacks 1024 576 Todd Coakwell

Returning capital to shareholders is a key part of a public company’s capital markets strategy. After funding growth and operations, management must decide how to give excess cash back to shareholders as part of their value creation plan. In this post, we explain the main ways of returning capital to shareholders – regular dividends, special…

Implementing AI in your capital markets function

Implementing Artificial Intelligence in Your Capital Markets Program

 Implementing Artificial Intelligence in Your Capital Markets Program 1024 576 Tom McMillan

Artificial intelligence has already become table stakes for corporate capital market functions. Laggards in adopting AI are already watching their valuation lag behind companies that are taking advantage of the efficiency, scale, and enhanced engagement made possible by AI.

Contact Us

The capital markets can be bewildering, even to the most experienced management teams. We believe that most executives are committed to maximizing shareholder value, but poorly executed investor relations can lead to valuation loss, reputational damage, employee attrition, deal failure, and even shareholder revolt.

MCI has helped its clients unlock billions of dollars in market value through a proven system that delivers sound messaging, branding, and engagement strategies. Over the past two decades our team has been involved in $5.7 billion in corporate actions that include $3.1 billion in acquisitions and $2.6 billion in financings-all successful.

MCI can help you resolve unfair valuation discounts and get the most out of your company’s public listing. Contact us today to engage our data driven, results focused process to unleash real progress.